Sg Americas Securities, LLC 9 Meters Biopharma, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
BUY
$0.26 - $0.64 $7,848 - $19,319
30,187 New
30,187 $8,000
Q1 2022

Apr 29, 2022
SELL
$0.52 - $1.0 $29,956 - $57,608
-57,608 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$0.85 - $1.33 $42,807 - $66,981
-50,362 Reduced 46.64%
57,608 $56,000
Q3 2021

Nov 01, 2021
BUY
$1.03 - $1.41 $82,841 - $113,404
80,429 Added 292.03%
107,970 $140,000
Q2 2021

Aug 12, 2021
BUY
$1.04 - $1.5 $28,642 - $41,311
27,541 New
27,541 $30,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email